Insulin's Role in Diabetes Management: After 90 Years, Still Considered the Essential "Black Dress".

Item

http://www.wikidata.org/entity/Q43158349

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@en

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@nl

type

Item

label

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@en

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@nl

prefLabel

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@en

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@nl

P1476

Insulin's Role in Diabetes Man ...... d the Essential "Black Dress".

@en

P2093

Matthew C Riddle

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.

Efficacy and Safety of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes.

Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.

Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.

P304

2200-2203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2337/DCI15-0023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Derek LeRoith

Julio Rosenstock

William T. Cefalu

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26604276

http://www.w3.org/2001/XMLSchema#string

P932

4657614

http://www.w3.org/2001/XMLSchema#string